Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Borje S. Andersson

Multi-Institutional Study of Post-Transplantation Cyclophosphamide as Single-Agent Graft-Versus-Host Disease Prophylaxis After Allogeneic Bone Marrow Transplantation Using Myeloablative Busulfan and Fludarabine Conditioning

Journal of Clinical Oncology

English

Comparison of Tacrolimus and Post-Transplant Cyclophosphamide (PTCy) With Tacrolimus and Methotrexate (Tac/Mtx) GVHD Prophylaxis in Patients With AML Undergoing Transplantation From Matched Related or Unrelated Donors

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2019

English

Haploidentical Hematopoietic Stem Cell Transplantation (Haplo-Sct) With Pre-Transplant Immunosuppression and Post-Transplant Cyclophosphamide (Post-Cy) in Severe Thalassemia: A Novel Approach Transplant for Nonmalignant Diseases

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2015

English

Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes Between CD34 + Selected or Unmodified Hematopoietic Stem Cells Transplants

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2018

English

Mixed T Lymphocyte Chimerism After Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2015

English

Myeloablative Timed Sequential Busulfan Is Safe in Patients With Relapsed or High-Risk Multiple Myeloma

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2016

English

Ex Vivo T Cell–Depleted Versus Unmodified Allografts in Patients With Acute Myeloid Leukemia in First Complete Remission

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2013

English

Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin's Lymphoma

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2018

English

5-Aza-2′-Deoxycytidine Sensitizes Busulfan-Resistant Myeloid Leukemia Cells by Regulating Expression of Genes Involved in Cell Cycle Checkpoint and Apoptosis

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Borje S. Andersson

Multi-Institutional Study of Post-Transplantation Cyclophosphamide as Single-Agent Graft-Versus-Host Disease Prophylaxis After Allogeneic Bone Marrow Transplantation Using Myeloablative Busulfan and Fludarabine Conditioning

Comparison of Tacrolimus and Post-Transplant Cyclophosphamide (PTCy) With Tacrolimus and Methotrexate (Tac/Mtx) GVHD Prophylaxis in Patients With AML Undergoing Transplantation From Matched Related or Unrelated Donors

Haploidentical Hematopoietic Stem Cell Transplantation (Haplo-Sct) With Pre-Transplant Immunosuppression and Post-Transplant Cyclophosphamide (Post-Cy) in Severe Thalassemia: A Novel Approach Transplant for Nonmalignant Diseases

Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes Between CD34 + Selected or Unmodified Hematopoietic Stem Cells Transplants

Mixed T Lymphocyte Chimerism After Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes

Myeloablative Timed Sequential Busulfan Is Safe in Patients With Relapsed or High-Risk Multiple Myeloma

Ex Vivo T Cell–Depleted Versus Unmodified Allografts in Patients With Acute Myeloid Leukemia in First Complete Remission

Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin's Lymphoma

5-Aza-2′-Deoxycytidine Sensitizes Busulfan-Resistant Myeloid Leukemia Cells by Regulating Expression of Genes Involved in Cell Cycle Checkpoint and Apoptosis